# OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
> **ANDA207437** · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2025-11-24
## Drug
- **FDA Application Number:** ANDA207437
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
- **Generic name:** OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MICRO LABS
- **Manufacturer:** Micro Labs Limited
- **First approval:** 2025-11-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207437)
---
*AI Analytics · CC0 1.0*